Elevance Health, Inc. - Common Stock (ELV)

CUSIP: 036752103

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
232,836,241
Total 13F shares
206,213,996
Share change
+1,072,610
Total reported value
$75,993,957,146
Put/Call ratio
87%
Price per share
$368.90
Number of holders
1,579
Value change
-$44,680,642
Number of buys
564
Number of sells
1,008

Quarterly Holders Quick Answers

What is CUSIP 036752103?
CUSIP 036752103 identifies ELV - Elevance Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ELV - Elevance Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
9.2%
21,347,194
$11,100,540,880 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
9%
21,033,626
$10,937,485,654 30 Sep 2024
13F
STATE STREET CORP
13F
Company
4.6%
10,687,998
$5,557,758,960 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
4.4%
10,153,925
$5,280,043,000 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.1%
4,848,020
$2,511,814,075 30 Sep 2024
13F
FMR LLC
13F
Company
2%
4,618,750
$2,401,750,249 30 Sep 2024
13F
Sanders Capital, LLC
13F
Company
2%
4,609,258
$2,396,814,160 30 Sep 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.9%
4,461,585
$2,320,024,200 30 Sep 2024
13F
Capital International Investors
13F
Company
1.7%
3,845,054
$1,999,657,351 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.6%
3,786,806
$1,969,149,564 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
1.5%
3,452,767
$1,795,440,417 30 Sep 2024
13F
NORGES BANK
13F
Company
1.3%
2,976,162
$1,547,604,240 30 Sep 2024
13F
BAILLIE GIFFORD & CO
13F
Company
1.2%
2,769,568
$1,440,175,360 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
1.1%
2,608,944
$1,356,650,728 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
1.1%
2,523,988
$1,312,474,557 30 Sep 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.1%
2,506,570
$1,303,416,400 30 Sep 2024
13F
Artisan Partners Limited Partnership
13F
Company
1%
2,438,747
$1,268,148,440 30 Sep 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
1%
2,397,258
$1,246,574,160 30 Sep 2024
13F
Invesco Ltd.
13F
Company
1%
2,381,808
$1,238,540,368 30 Sep 2024
13F
First Eagle Investment Management, LLC
13F
Company
0.94%
2,185,727
$1,136,578,175 30 Sep 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.92%
2,152,613
$1,119,358,760 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.9%
2,102,471
$1,093,284,920 30 Sep 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.9%
2,091,969
$1,087,823,880 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.86%
1,995,522
$1,037,671,430 30 Sep 2024
13F
Legal & General Group Plc
13F
Company
0.77%
1,797,895
$934,904,882 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.76%
1,778,856
$925,046,022 30 Sep 2024
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.72%
1,684,234
$882,454,404 30 Sep 2024
13F
Grantham, Mayo, Van Otterloo & Co. LLC
13F
Company
0.72%
1,684,658
$876,022,160 30 Sep 2024
13F
Brave Warrior Advisors, LLC
13F
Company
0.7%
1,641,413
$853,534,760 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.69%
1,611,242
$837,845,856 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.69%
1,609,444
$836,910,469 30 Sep 2024
13F
EAGLE CAPITAL MANAGEMENT LLC
13F
Company
0.69%
1,600,230
$832,119,600 30 Sep 2024
13F
EdgePoint Investment Group Inc.
13F
Company
0.56%
1,312,692
$682,599,840 30 Sep 2024
13F
Amundi
13F
Individual
0.57%
1,332,508
$652,222,690 30 Sep 2024
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
0.53%
1,243,001
$646,360,520 30 Sep 2024
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.53%
1,232,238
$640,209,254 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.52%
1,212,839
$617,358,609 30 Sep 2024
13F
Newport Trust Company, LLC
13F
Company
0.48%
1,128,406
$586,771,120 30 Sep 2024
13F
Veritas Asset Management LLP
13F
Company
0.47%
1,097,778
$570,844,560 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.45%
1,048,126
$545,025,520 30 Sep 2024
13F
Ruane, Cunniff & Goldfarb L.P.
13F
Company
0.43%
1,004,533
$522,357,160 30 Sep 2024
13F
Orbis Allan Gray Ltd
13F
Company
0.39%
904,897
$470,546,440 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.38%
893,412
$464,574,240 30 Sep 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
0.37%
856,589
$445,426,280 30 Sep 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.37%
852,407
$443,251,632 30 Sep 2024
13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC
13F
Company
0.37%
850,640
$442,332,800 30 Sep 2024
13F
UBS Group AG
13F
Company
0.35%
818,440
$425,588,800 30 Sep 2024
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.34%
793,915
$412,835,800 30 Sep 2024
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.34%
790,440
$411,028,800 30 Sep 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.34%
785,223
$407,977,771 30 Sep 2024
13F

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2024

As of 31 Dec 2024, Elevance Health, Inc. - Common Stock (ELV) was held by 1,579 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 206,213,996 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Sanders Capital, LLC, Capital International Investors, First Eagle Investment Management, LLC, and NORGES BANK. This page lists 1,590 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
1,677
Q4 2024 holders
1,579
Holder diff
-98
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .